Cargando…
Co‐administration of Antimicrobial Peptides Enhances Toll‐like Receptor 4 Antagonist Activity of a Synthetic Glycolipid
This study examines the effect of co‐administration of antimicrobial peptides and the synthetic glycolipid FP7, which is active in inhibiting inflammatory cytokine production caused by TLR4 activation and signaling. The co‐administration of two lipopolysaccharide (LPS)‐neutralizing peptides (a cecro...
Autores principales: | Facchini, Fabio A., Coelho, Helena, Sestito, Stefania E., Delgado, Sandra, Minotti, Alberto, Andreu, David, Jiménez‐Barbero, Jesús, Peri, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900894/ https://www.ncbi.nlm.nih.gov/pubmed/29265636 http://dx.doi.org/10.1002/cmdc.201700694 |
Ejemplares similares
-
Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophages
por: Palmer, Charys, et al.
Publicado: (2021) -
Synthetic Glycolipids
as Molecular Vaccine Adjuvants:
Mechanism of Action in Human Cells and In Vivo Activity
por: Facchini, Fabio A., et al.
Publicado: (2021) -
Synthetic Phenolic Glycolipids for Application in Diagnostic Tests for Leprosy
por: van Dijk, J. Hessel M., et al.
Publicado: (2021) -
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties
por: Cochet, Florent, et al.
Publicado: (2019) -
The synthetic glycolipid-based TLR4 antagonist FP7 negatively
regulates in vitro and in vivo haematopoietic
and non-haematopoietic vascular TLR4 signalling
por: Palmer, Charys, et al.
Publicado: (2018)